CORE-008 ? BIOMEDICAL INFORMATICS SHARED RESOURCE (BISR) PROJECT SUMMARY / ABSTRACT The OSUCCC Biomedical Informatics Shared Resource (BISR) provides a comprehensive suite of services, technologies and expertise that collectively support the resource-efficient conduct of basic, clinical/translational and population science for OSUCCC investigators.
The Specific Aims of the BISR are: 1) to provide state-of- the-art bioinformatics and computational biology services for the analysis of massively parallel sequence data and the analysis of microarray datasets; 2) to provide OSUCCC investigators with services, expertise and access to technology platforms in support of heterogeneous and multi-dimensional biomedical data management requirements., The BISR, directed by Drs. Jeff Parvin (Aim 1) and Philip Payne (Aim 2), is supported through a combination of CCSG and project-specific grant funds (via charge-back mechanisms), as well as significant and ongoing institutional commitments of human, computational, and financial resources. During the prior five year grant period, the BISR was used by 45 OSUCCC members (59% of total users), but they accounted for 95.7% of usage. The BISR contributed to 195 publications, 29 with a journal impact factor greater than 10 and supported 21 NCI grants through billable services (charegebacks) (1 K12, 1 K24, 4 P01s, 2 P50s, 7 R01s, 1 R21, 1 R37, 1 RC2, 1 U01, 1 U10, and 1 U54). This is in addition to 18 BISR (Aim 1) staff members who have had directly funded appointments on NCI grants (i.e., 3 P01s, 2 P50s, 8 R01s, 1 R21, 1 RC2, 4 U01s, and 1 U54), other grants, and/or OSUCCC institutional funding sources. Through this work, BISR supported investigators from all five of the OSUCCC research programs. The BISR works closely and coordinates services with other OSUCCC shared resources, namely the Behavioral Measurement Shared Resource, the Genomics Shared Resource, the Biostatistics Shared Resource and the Biospecimen Services Shared Resource with its Total Care Cancer protocol. The future plans of the BISR are to streamline and strengthen existing next generation sequencing (NGS) data analysis pipelines through integration of new commercial programs, establish novel data visualization and visual analytics platforms, enhance the OSUCCC researchers abilities to access clinical data through an OSUCCC Information Warehouse serving as the honest broker and employing innovative electronic data capture tools, and fully implementing the Total Cancer Care protocol integration with other cancer centers for real time access to larger sets of electronic health records linked to biospecimens. The BISR leverages extensive institutional support and seeks only 7.0% support from CCSG funds. The Biomedical Informatics Shared Resource is part of the Analytics Grouping.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-41
Application #
9221253
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
41
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Sadowski, Abbey R; Gardner, Heather L; Borgatti, Antonella et al. (2018) Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma. BMC Vet Res 14:250
Barredo, Julio C; Hastings, Caroline; Lu, Xiamin et al. (2018) Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study. Pediatr Blood Cancer 65:e26928
Kim, So-Youn; Nair, Devi M; Romero, Megan et al. (2018) Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies. Cell Death Differ :
Yadav, Marshleen; Song, Feifei; Huang, Jason et al. (2018) Ocimum flavone Orientin as a countermeasure for thrombocytopenia. Sci Rep 8:5075
Siegel, Marni B; He, Xiaping; Hoadley, Katherine A et al. (2018) Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest 128:1371-1383
White, Brian S; Lanc, Irena; O'Neal, Julie et al. (2018) A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer J 8:35
Owen, Dwight; Chaft, Jamie E (2018) Immunotherapy in surgically resectable non-small cell lung cancer. J Thorac Dis 10:S404-S411
O'Brien, Susan M; Jaglowski, Samantha; Byrd, John C et al. (2018) Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials. JAMA Oncol 4:712-716
Guo, Sijin; Piao, Xijun; Li, Hui et al. (2018) Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor. Methods 143:121-133
Pan, Pan; Huang, Yi-Wen; Oshima, Kiyoko et al. (2018) An immunological perspective for preventing cancer with berries. J Berry Res 8:163-175

Showing the most recent 10 out of 2602 publications